- Home
- TCOM vs DXCM Comparison
TCOM vs DXCM Comparison
Compare TCOM & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCOM
- DXCM
- Stock Information
- Founded
- TCOM 1999
- DXCM 1999
- Country
- TCOM Singapore
- DXCM United States
- Employees
- TCOM N/A
- DXCM N/A
- Industry
- TCOM Hotels/Resorts
- DXCM Medical/Dental Instruments
- Sector
- TCOM Consumer Discretionary
- DXCM Health Care
- Exchange
- TCOM Nasdaq
- DXCM Nasdaq
- Market Cap
- TCOM 36.1B
- DXCM 34.1B
- IPO Year
- TCOM 2003
- DXCM 2005
- Fundamental
- Price
- TCOM $62.65
- DXCM $85.80
- Analyst Decision
- TCOM Strong Buy
- DXCM Strong Buy
- Analyst Count
- TCOM 10
- DXCM 19
- Target Price
- TCOM $77.88
- DXCM $98.32
- AVG Volume (30 Days)
- TCOM 2.9M
- DXCM 3.8M
- Earning Date
- TCOM 05-19-2025
- DXCM 07-24-2025
- Dividend Yield
- TCOM 0.45%
- DXCM N/A
- EPS Growth
- TCOM 51.63
- DXCM N/A
- EPS
- TCOM 3.38
- DXCM 1.33
- Revenue
- TCOM $7,609,591,404.00
- DXCM $4,148,000,000.00
- Revenue This Year
- TCOM $17.32
- DXCM $16.66
- Revenue Next Year
- TCOM $14.47
- DXCM $15.35
- P/E Ratio
- TCOM $19.12
- DXCM $64.41
- Revenue Growth
- TCOM 16.95
- DXCM 9.11
- 52 Week Low
- TCOM $38.23
- DXCM $57.52
- 52 Week High
- TCOM $77.18
- DXCM $127.61
- Technical
- Relative Strength Index (RSI)
- TCOM 51.18
- DXCM 61.53
- Support Level
- TCOM $60.85
- DXCM $84.51
- Resistance Level
- TCOM $65.25
- DXCM $87.67
- Average True Range (ATR)
- TCOM 1.50
- DXCM 2.06
- MACD
- TCOM -0.22
- DXCM -0.42
- Stochastic Oscillator
- TCOM 27.31
- DXCM 55.37
About TCOM Trip.com Group Limited
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from its online platform, but the company also maintains offline call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.